Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Med Suisse ; 5(224): 2229-30, 2232-4, 2009 Nov 04.
Artigo em Francês | MEDLINE | ID: mdl-19994672

RESUMO

Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. IV iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last IV iron administration.


Assuntos
Deficiências de Ferro , Deficiências Nutricionais/diagnóstico , Deficiências Nutricionais/tratamento farmacológico , Humanos
2.
Praxis (Bern 1994) ; 98(24): 1445-51, 2009 Dec 02.
Artigo em Alemão | MEDLINE | ID: mdl-19953470

RESUMO

Iron deficiency (ID) without anaemia frequently remains undiagnosed when symptoms are attributed to ID with anaemia. Serum ferritin is the primary diagnostic parameter, whereas <10 microg/l represent depleted iron stores, 10-30 microg/l can confirm ID without anaemia and 30-50 microg/l might indicate functional ID. In case of increased CRP or ALT, normal/elevated ferritin should be interpreted with caution. Intravenous iron is indicated if oral iron is not effective or tolerated. At ferritin <10 microg/l, a cumulative dose of 1000 mg iron and at ferritin 10-30 microg/l, a cumulative dose of 500 mg is advised. At ferritin 30-50 microg/l a first dose of 200 mg might be considered. Ferritin shall be reassessed not sooner than 2 weeks after the last oral or 8-12 weeks after the last iv iron administration.


Assuntos
Anemia Ferropriva/diagnóstico , Deficiências de Ferro , Alopecia/sangue , Alopecia/etiologia , Anemia Ferropriva/sangue , Transtornos Cognitivos/sangue , Transtornos Cognitivos/etiologia , Estudos Transversais , Diagnóstico Diferencial , Formas de Dosagem , Fadiga/sangue , Fadiga/etiologia , Ferritinas/sangue , Humanos , Ferro/administração & dosagem , Ferro/sangue , Compostos de Ferro/administração & dosagem , Compostos de Ferro/efeitos adversos , Valores de Referência , Síndrome das Pernas Inquietas/sangue , Síndrome das Pernas Inquietas/etiologia
3.
Praxis (Bern 1994) ; 92(48): 2044-9, 2003 Nov 26.
Artigo em Alemão | MEDLINE | ID: mdl-14694542

RESUMO

Many chronic pain conditions cannot be classified correctly into the actual categories of nociceptive, neuropathic, or psychogenic pain. The experience that a therapeutic influence on the vegetative nervous system often improves these pains or induces healing of them suggests a classification into four pain types. The inclusion of the autonomic component in the appreciation, and the treatment of chronic pain conditions using measures acting on the vegetative nervous system (such as local anesthetics in the neural therapy of Huneke) will consistently enlarge and improve the understanding and the outcome in pain therapy.


Assuntos
Aminas , Ácidos Cicloexanocarboxílicos , Manejo da Dor , Dor/classificação , Ácido gama-Aminobutírico , Acetatos/uso terapêutico , Adulto , Analgésicos/uso terapêutico , Analgésicos Opioides/uso terapêutico , Anestésicos Locais/uso terapêutico , Dor nas Costas/tratamento farmacológico , Doença Crônica , Cicatriz/complicações , Terapias Complementares , Feminino , Gabapentina , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos de Enxaqueca/tratamento farmacológico , Nociceptores/fisiologia , Dor/tratamento farmacológico , Dor/etiologia , Dor/fisiopatologia , Dor/psicologia , Modalidades de Fisioterapia , Procaína/uso terapêutico , Distrofia Simpática Reflexa/diagnóstico , Distrofia Simpática Reflexa/terapia , Tramadol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...